CSGALNACT2 Antikörper (AA 200-229)

Produktnummer ABIN652723

Produktdetails anti-CSGALNACT2 Antikörper

Target: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Bindungsspezifität: AA 200-229

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CSGALNACT2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This CSGALNACT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-229 amino acids from the Central region of human CSGALNACT2.

Klon: RB23569

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Haltbarkeit: 6 months

Referenzen für anti-CSGALNACT2 Antikörper (ABIN652723)

Anggraeni, Emoto, Yagi, Mayasari, Nakayama, Izumikawa, Kitagawa, Hirata: "Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis." in: Biochemical and biophysical research communications, Vol. 406, Issue 1, pp. 36-41, (2011) (PubMed).

Details zu CSGALNACT2

Target: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Andere Bezeichnung: CSGALNACT2 (CSGALNACT2 Produkte)

Hintergrund: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). It is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.

Molekulargewicht: 62572

Gen-ID: 55454

NCBI Accession: NP_061060

UniProt: Q8N6G5

Pathways: Glycosaminoglycan Metabolic Process